InSyBio is a pioneering bioinformatics company specializing in personalized medicine through advanced computational tools and machine learning algorithms. Their platform is designed to analyze complex biological data, enabling researchers and healthcare professionals to uncover biomarkers and develop targeted therapies.
Key Features and Functionality:
- Biomarker Discovery: Utilizes sophisticated algorithms to identify potential biomarkers from various biological datasets, facilitating early disease detection and personalized treatment plans.
- Data Integration: Combines diverse data types, including genomics, proteomics, and metabolomics, to provide a comprehensive understanding of biological systems.
- Machine Learning Models: Employs advanced machine learning techniques to predict disease outcomes and treatment responses, enhancing the precision of medical interventions.
- User-Friendly Interface: Offers an intuitive platform that allows users to easily input data, run analyses, and interpret results without extensive bioinformatics expertise.
Primary Value and Solutions:
InSyBio addresses the challenge of translating complex biological data into actionable insights for personalized medicine. By streamlining the biomarker discovery process and integrating multiple data sources, it empowers researchers and clinicians to develop more effective, individualized treatment strategies, ultimately improving patient outcomes and advancing the field of precision healthcare.
The System Report Handler for PureConnect is a specialized tool designed to enhance the reporting capabilities within the Customer Interaction Center (CIC environment. It automates the execution of reporting tasks by integrating seamlessly with the CIC reporting system, thereby streamlining the generation and management of reports.
Key Features and Functionality:
- Automated Report Execution: Utilizes handler steps to invoke the I3RunCrReport executable within the CIC environment, passing necessary parameters via a named pipe for efficient report generation.
- Synchronous Operation: Operates synchronously, awaiting completion codes from report executions to ensure accurate and timely reporting.
- Resource Management: Limits concurrent report executions to five instances to maintain system performance, with a timeout mechanism to handle prolonged executions.
- Error Handling: Incorporates safeguards to terminate reports exceeding a ten-minute execution time, preventing potential system degradation and addressing issues like unresponsive processes.
Primary Value and User Benefits:
The System Report Handler addresses the need for efficient and reliable report generation within the PureConnect platform. By automating reporting tasks and managing system resources effectively, it ensures that organizations can produce timely and accurate reports without compromising system performance. This automation reduces manual intervention, minimizes errors, and enhances the overall efficiency of contact center operations.
Pizza EAT è il gestionale pensato per le pizzerie e per chi lavora con asporto e consegne a domicilio.
Riunisce in un solo sistema la presa degli ordini al banco, al telefono e online, il monitor della cucina, la gestione della sala e dei tavoli, le consegne con l'app per i rider, la cassa e le statistiche.
Comprende un'app di ordinazione con il marchio della pizzeria: i clienti ordinano direttamente dal locale, senza commissioni sugli ordini e senza intermediari.
Il menù non va inserito a mano. Si fotografa il menù cartaceo e l'intelligenza artificiale lo importa in circa un minuto, prezzi compresi, generando anche le immagini dei piatti.
Le comande vengono stampate su stampanti termiche da 80 mm in uno o due secondi, con reparti separati per forno, bar, dolci e cassa, collegate via rete, Wi-Fi, USB o Bluetooth.
Funziona su PC, Mac, Linux, tablet Android, iPhone e iPad. È disponibile in 5 lingue e gestisce 57 valute.
Prova gratuita di 90 giorni, senza carta di credito.
Quris-AI is a pioneering biotechnology company that leverages artificial intelligence and advanced genomic technologies to revolutionize drug development. By integrating AI-driven predictive models with patient-derived tissue samples, Quris-AI aims to enhance the accuracy and efficiency of preclinical drug testing, reducing the reliance on animal models and increasing the likelihood of clinical success.
Key Features and Functionality:
- AI-Powered Drug Testing: Utilizes machine learning algorithms to predict drug efficacy and safety, streamlining the preclinical testing phase.
- Patient-on-a-Chip Technology: Employs microfluidic devices that mimic human organ systems, allowing for more accurate simulation of human responses to drugs.
- Data-Driven Insights: Analyzes vast datasets to identify potential drug candidates and optimize therapeutic strategies.
- Reduced Animal Testing: Offers an ethical and more predictive alternative to traditional animal testing methods.
Primary Value and User Solutions:
Quris-AI addresses the high failure rates and ethical concerns associated with conventional drug development processes. By providing a more accurate and humane testing platform, it enables pharmaceutical companies to identify promising drug candidates earlier, reduce development costs, and accelerate the time-to-market for new therapies. This approach not only enhances patient safety but also increases the overall efficiency and success rates of drug development pipelines.
Biotronics AI is a pioneering company dedicated to transforming the life sciences sector through advanced technologies such as machine learning and quantum computing. Their mission is to develop innovative solutions that address complex challenges in healthcare, forensic science, and sustainability.
Key Features and Functionality:
- MediSight: A platform designed to receive, analyze, and diagnose various types of biomedical data. Its standout feature is the ability to simulate the progression of lesion findings in subsequent phases of a disease, providing valuable insights into disease development.
- ForenSight: An open-source suite of tools developed to assist forensic genetic experts in performing DNA comparisons. It significantly reduces the time required for DNA comparisons from days to mere seconds, enhancing the efficiency of forensic investigations.
- Bio-Q: A quantum machine learning algorithm designed to calculate the molecular structure of cellular and nuclear receptors using genomic information. Bio-Q facilitates the design of corresponding molecular microanatomy, making it the first quantum circuit developed for this purpose.
Primary Value and User Solutions:
Biotronics AI addresses critical issues in the life sciences by providing technologies that enhance diagnostic accuracy, expedite forensic analyses, and accelerate drug discovery processes. By integrating machine learning and quantum computing, their solutions offer unprecedented speed and precision, ultimately improving patient outcomes, supporting justice systems, and promoting sustainability initiatives.
The "Feasibility Analysis of Cancer Trial" is a comprehensive solution designed to streamline the planning and execution of cancer clinical trials. By integrating advanced data analytics and cloud computing capabilities, this product enables researchers and healthcare professionals to assess the viability of proposed trials efficiently. It facilitates the evaluation of patient recruitment potential, resource allocation, and overall trial design, ensuring that studies are both scientifically sound and operationally feasible.
Key Features and Functionality:
- Data Integration: Aggregates and analyzes diverse datasets, including genomic, clinical, and imaging data, to provide a holistic view of trial feasibility.
- Predictive Analytics: Utilizes machine learning algorithms to forecast patient enrollment rates and identify potential challenges in trial execution.
- Resource Optimization: Assesses the availability and allocation of necessary resources, such as personnel, equipment, and facilities, to ensure efficient trial operations.
- Regulatory Compliance: Ensures that trial designs adhere to ethical standards and regulatory requirements, facilitating smoother approval processes.
- Collaborative Platform: Provides a centralized interface for stakeholders to collaborate, share insights, and make informed decisions throughout the trial planning phase.
Primary Value and Problem Solved:
The primary value of the "Feasibility Analysis of Cancer Trial" lies in its ability to reduce the time and cost associated with the initial stages of clinical trial planning. By offering predictive insights and comprehensive analyses, it helps researchers identify and mitigate potential obstacles early in the process. This proactive approach enhances the likelihood of successful trial outcomes, accelerates the development of new cancer therapies, and ultimately contributes to improved patient care.
Actum, s.r.o., operating as ACTUM Digital, is a Czech-based digital agency specializing in advanced digital solutions that enhance customer experience, commerce, and data management. With over 28 years of experience, ACTUM Digital serves a diverse clientele across Western Europe, the USA, and Scandinavia, delivering tailored digital strategies and technology platforms.
Key Features and Functionality:
- Comprehensive Digital Services: ACTUM Digital offers a wide range of services, including website development, e-commerce solutions, product data management, customer engagement, process automation, CRM, enterprise search, SAP ERP, cloud applications, ESG advisory, ECM, experience design, supply chain management, system integration, cybersecurity, and team outsourcing.
- Process Automation: Utilizing Microsoft Power Platform, ACTUM Digital develops cost-effective business applications and implements robotic process automation to eliminate repetitive tasks associated with legacy systems.
- Strategic Partnerships: The company is a certified implementation partner with leading technology providers such as Kentico, Sitecore, Microsoft, Salesforce, SAP, Kontent.ai, Inriver, Adobe, BigCommerce, Bloomreach, AWS, Phrase, Keboola, and Tableau.
Primary Value and Solutions:
ACTUM Digital empowers organizations to outperform competitors by providing tailored digital platforms that drive transformation. Their solutions address the need for efficient digitalization, enhanced customer engagement, and streamlined business processes. By leveraging cutting-edge technologies and strategic partnerships, ACTUM Digital ensures that businesses have the right tools to succeed in the digital age.
Polipush è la piattaforma italiana B2B per la gestione della posta ibrida aziendale, certificata da Poste Italiane.
Integra 13 canali di comunicazione in un'unica soluzione 100% cloud.
Polipush permette alle aziende di gestire tutte le comunicazioni verso i propri clienti da un'unica piattaforma: dalla posta cartacea alle notifiche digitali, con tracciamento completo e archivio legale fino a 10 anni. Sviluppato in Italia, GDPR compliant.
Posta massiva, posta tradizionale, raccomandata A/R, raccomandata digitale, PEC, SMS, email, notifiche push, telegramma, FTP/SFTP, archiviazione cloud, atti giudiziari, firme digitali.
Funzionalità principali
- Document Composition con editor online (simile a Word)
- Calcolo immediato del preventivo di spesa in tempo reale
- Gestione budget per centro di costo con report esportabili
- Tracking online rendicontazioni esportabili 24/7
- Archivio digitale consultabile fino a 10 anni con valore legale
- API REST e FTP/SFTP per integrazione con ERP e CRM aziendali
- Login Multi-Company per gruppi aziendali e holding
- Push notification: oltre 10 milioni al mese
- Integrazione con chatbot AI per marketing automation
- Gestione protocollazione con codice personalizzato
- Backup automatico spedizioni via SFTP
- Form dinamici per iscrizioni e sondaggi
Signet Therapeutics is a clinical-stage biotechnology company pioneering the development of first-in-class targeted cancer therapies by integrating organoid disease models with artificial intelligence (AI). Their innovative approach accelerates drug discovery and enhances the precision of treatments, particularly for cancers that are unresponsive to conventional therapies.
Key Features and Functionality:
- Organoid Disease Models: Utilizes three-dimensional organoid models derived from patient genomics to closely mimic human biology, enabling accurate evaluation of drug efficacy and identification of novel therapeutic targets.
- AI-Driven Drug Discovery: Employs AI and robotics to streamline the identification, design, and optimization of small-molecule compounds, significantly reducing the time from target discovery to clinical trials.
- Innovative Drug Pipeline: Developed SIGX1094, the world's first targeted therapy for diffuse gastric cancer (DGC), which has received FDA Orphan Drug Designation and Fast Track Designation, and is currently in Phase I clinical trials.
- Collaborative Platform: Offers its organoid platform for external collaborations, providing preclinical drug discovery and development services to biotech and pharmaceutical partners.
Primary Value and Solutions:
Signet Therapeutics addresses the critical need for effective treatments in aggressive and treatment-resistant cancers. By combining organoid models with AI, they enhance the predictability and efficiency of drug development, leading to faster clinical advancements and potentially higher success rates. Their approach not only accelerates the discovery of novel therapies but also offers hope to patients with limited treatment options, particularly those suffering from cancers like diffuse gastric cancer.
Mystra is a comprehensive software solution designed to streamline business operations by integrating various functionalities into a single platform. It offers tools for project management, customer relationship management (CRM), and financial tracking, enabling organizations to enhance productivity and efficiency.
Key Features and Functionality:
- Project Management: Facilitates task assignment, progress tracking, and team collaboration to ensure timely project completion.
- Customer Relationship Management (CRM): Manages customer interactions, sales pipelines, and support tickets to improve client satisfaction and retention.
- Financial Tracking: Monitors expenses, generates invoices, and provides financial reports to maintain fiscal health.
- Integration Capabilities: Seamlessly connects with existing tools and platforms to unify business processes.
- User-Friendly Interface: Offers an intuitive design that simplifies navigation and reduces the learning curve for new users.
Primary Value and Solutions Provided:
Mystra addresses the challenge of managing multiple business functions by consolidating them into a single, cohesive platform. This integration reduces the need for multiple disparate systems, thereby decreasing operational complexity and costs. By providing real-time insights and facilitating efficient workflows, Mystra empowers businesses to make informed decisions, enhance team collaboration, and ultimately drive growth and success.
Optivaa is an AI operating layer for dental practices that works with your existing practice management software—no migration required.
Rather than replacing systems like Dentrix, Open Dental, Eaglesoft, Curve Dental, Denticon, CareStack, and other leading practice management platforms, Optivaa securely integrates with them to bring AI-powered automation and patient engagement into your existing workflow.
Optivaa transforms your current practice management system into an intelligent, always-on virtual front desk. It automates appointment scheduling, AI phone calls, SMS and email communication, appointment reminders, confirmations, recalls, patient follow-ups, and other administrative workflows—all while keeping your existing software as the single source of truth.
Because Optivaa operates as an intelligent layer above your existing PMS, dental practices can adopt powerful AI capabilities without disrupting daily operations, retraining staff on a new system, or migrating years of patient data.
Whether managing a single clinic or a multi-location dental organization, Optivaa helps practices reduce administrative workload, improve patient responsiveness, minimize no-shows, and increase appointment utilization through seamless AI-driven automation.
Key Features
AI voice agent for inbound and outbound patient calls
Automated appointment scheduling and rescheduling
SMS and email reminders, confirmations, and recalls
Works with existing practice management software
No database migration required
Patient follow-up and reactivation campaigns
Real-time synchronization with practice data
Multi-location practice support
HIPAA-conscious data handling and secure integrations
Analytics and operational insights
Immunai is a biotechnology company dedicated to mapping the human immune system with unprecedented scale and resolution. By integrating single-cell genomics with advanced machine learning algorithms, Immunai aims to accelerate the discovery and development of novel immune-related therapeutics. Their platform provides comprehensive insights into immune mechanisms, facilitating smarter decision-making in drug development and personalized medicine.
Key Features and Functionality:
- Target Discovery: Identifies novel, high-impact targets linked to various diseases, enabling the development of more effective therapies.
- Preclinical Evaluation: Prioritizes promising drug candidates by assessing their potential efficacy and safety, ensuring a higher success rate in subsequent clinical trials.
- Clinical Trial Optimization: Enhances understanding of drug mechanisms of action, identifies optimal patient groups, and refines treatment strategies to maximize clinical trial success.
- AMICA Database: Utilizes the Annotated Multiomic Immune Cell Atlas (AMICA), the world's largest immune-focused, harmonized single-cell database, to enrich generated data and provide deeper, more precise insights.
- Machine Learning Integration: Employs advanced machine learning platforms to compute novel immune features, linking immune mechanisms to treatment responses and outcomes.
Primary Value and Problem Solved:
Immunai addresses the complexity and challenges inherent in drug development by providing a comprehensive platform that decodes the immune system. By offering detailed insights into immune responses and mechanisms, Immunai empowers pharmaceutical companies and research institutions to make informed decisions, reduce risks, and accelerate the development of effective immune-related therapies. This approach not only enhances the efficiency of drug discovery but also paves the way for personalized treatment strategies, ultimately improving patient outcomes.
CardiaTec is a pioneering TechBio company dedicated to transforming cardiovascular disease treatment through advanced computational modeling and multi-omics data analysis. By integrating genomics, epigenomics, transcriptomics, and proteomics from human cardiac tissues, CardiaTec aims to uncover novel therapeutic targets and develop first-in-class cardiovascular therapies. The company has established a proprietary multi-omics dataset, sourced from a network of 65 hospitals across the UK and US, to support its innovative research initiatives.
Key Features and Functionality:
- Comprehensive Multi-Omics Data Integration: CardiaTec combines various biological data layers to provide a holistic understanding of cardiovascular disease mechanisms.
- Advanced Computational Modeling: Utilizing state-of-the-art AI algorithms, the company analyzes complex datasets to identify and prioritize dysregulated drug targets and disease-related pathways.
- Proprietary Data Strategy: With access to human cardiac tissues and corresponding clinical annotations, CardiaTec has built the largest human cardiac tissue multi-omics database, enhancing the discovery of truly novel therapeutics.
Primary Value and Problem Solved:
Cardiovascular disease remains the leading cause of death globally, claiming approximately 20 million lives annually. Traditional therapeutic development has been hindered by a limited understanding of the disease's complex biology, resulting in stagnated innovation and investment. CardiaTec addresses this challenge by leveraging its proprietary multi-omics dataset and computational platform to decode the intricate mechanisms driving disease progression. This approach facilitates the discovery and development of novel, targeted therapies, aiming to improve patient outcomes and reduce the global burden of cardiovascular diseases.
MultiOmic Health is an AI-enabled drug discovery company dedicated to developing precision medicines for metabolic syndrome-related conditions. Metabolic syndrome encompasses a cluster of risk factors—including dysglycemia, hypertension, dyslipidemia, and obesity—that can lead to serious health issues such as atherosclerotic cardiovascular disease, type 2 diabetes, chronic kidney disease, and non-alcoholic fatty liver disease. These conditions represent a significant global healthcare burden, accounting for 45% of all deaths worldwide and consuming $2 trillion in healthcare costs as of 2019.
Key Features and Functionality:
- Integrated Multi-Omics Analysis: The company employs a comprehensive approach by analyzing various biological data layers, including genomics, epigenomics, proteomics, and metabolomics. This multi-omics strategy provides a holistic understanding of disease biology at the molecular level.
- AI-Enabled Data Science: Utilizing advanced machine learning and AI techniques, MultiOmic Health processes complex patient datasets to identify distinct molecular drivers of disease within specific patient subpopulations.
- Computational Systems Biology Modeling: The company integrates computational models to simulate disease pathways, enhancing the understanding of disease mechanisms and informing therapeutic development.
- Targeted Wet Laboratory Experiments: Insights derived from data analysis and modeling are validated through laboratory experiments, ensuring the accuracy and applicability of findings.
Primary Value and Solutions:
MultiOmic Health addresses the unmet need for effective treatments in metabolic syndrome-related diseases by developing precision therapeutics tailored to specific patient subpopulations. This personalized approach aims to improve patient outcomes by targeting the unique molecular drivers of disease, thereby enabling shorter and more efficient clinical trials with higher success rates. Additionally, the development of companion diagnostics facilitates patient stratification and treatment monitoring, further enhancing the effectiveness of therapeutic interventions.
Infiuss Health is revolutionizing clinical research by introducing AI-powered solutions that streamline the design and execution of randomized controlled trials. Their flagship platform, Probe, enables researchers to simulate real patient responses before initiating studies, thereby enhancing the accuracy and efficiency of clinical trials.
Key Features and Functionality:
- Digital Patient Twin: Creates dynamic virtual representations of patients by integrating comprehensive health data, including medical records, genomics, imaging, lab results, and wearable device information.
- AI-Powered Predictions: Utilizes advanced artificial intelligence to simulate disease progression and predict treatment outcomes, allowing for proactive healthcare interventions.
- Data Integration & Interoperability: Seamlessly integrates with Electronic Health Records (EHRs), wearables, and Internet of Things (IoT) devices, ensuring real-time data synchronization and compliance with HIPAA standards.
- Clinical Research Insights: Provides AI-driven tools to assist researchers in protocol design and trial planning, enhancing the quality and efficiency of clinical studies.
- Predictive Analytics & Simulation: Offers advanced forecasting capabilities, including "what-if" scenario modeling and early warning systems, to support proactive patient care.
- Real-Time Monitoring & Alerts: Enables continuous health tracking with automated anomaly detection and proactive intervention triggers, facilitating timely medical responses.
- Patient Engagement Tools: Features interactive health dashboards and personalized recommendations to enhance patient involvement and adherence to treatment protocols.
Primary Value and Solutions Provided:
Infiuss Health addresses critical challenges in modern healthcare by bridging the gap between laboratory research and real-world patient outcomes. By leveraging AI and comprehensive data integration, the platform enhances research accuracy, reduces adverse events, and accelerates the discovery of effective treatments. This approach not only improves patient care but also optimizes clinical operations, leading to significant cost reductions and more efficient healthcare delivery.
Easily build a CleanPlex Custom NGS Amplicon Panel to accelerate your research and assay development. Multiplex up to 20,000+ amplicons in each reaction and take advantage of CleanPlex Technology’s high sensitivity, rapid single-tube workflow, and cost-effective sequencing.
Use ParagonDesigner™, our free, web-based tool, to submit your target regions of interest and instantly receive a design coverage report to review. Our custom amplicon panel design experts will be available through the process to provide you a quote, help you with any questions, and make further optimization to meet your needs. Once you approve the design, your custom NGS amplicon panel will be ready for shipment in 4 weeks.
Specialist in: Python, ROR, .NET, JAVA, Angular.JS, React.JS, IoT, Data Science, AI, BigData, BlockChain, Ethereum, dApp, Mobile, Web and more
At COLAN, we create meaningful and compelling user experiences for mobile, web and desktop applications. Driven by user-centered insights, strategy, and design, we deliver transformational products for IT, product group and marketing professionals in the mobility, enterprise, healthcare, finance, travel & leisure and consumer industries.
Since the company’s inception in 2009, COLAN has worked more than 800+ projects worldwide in several verticals from successful small businesses to large and publicly traded companies.
Platforms: .NET Framework, ASP.NET Core Languages: C#, ASP.NET 4.0, 4.5, VB.NET Architecture: MVC, MVVM, n-tier CMS: Umbraco, Sitecore, Sitefinity, DotNetNuke, Kentico Web Services: WCF, ASMX, WebApi Cloud Hosting: Microsoft Azure, Amazon Web Services Database: MS SQL Server, Microsoft HD Insight, Hadoop, MongoDB, Oracle BI / Reporting Tools: Power BI, SSAS, SSIS, SSRS
Platforms: Core-Java,JEE Languages: Java Architecture: MVC,n-tier Frameworks: Spring,Struts,Hibernate,IBatis,Toplink,SpringREST CMS: Magnolia,OpenCMS,Alfresco Web Services: REST,SOAP Cloud Hosting: Amazon Web Services Database: MySQL,MSSQL,Oracle,Cassandra,MongoDB,Amazon RDS Search Engine:Apache Solr,Elastic Search Big Data:Hadoop Ecosystem BI / Reporting Tools: Jasper Report,Crystal Reports
Programming Languages : PHP 5.6, 7.0 PHP CMS & E-Commerce : Core PHP, Wordpress 4.7.3, 4.7.5 , Drupal 7.56, 8.2, Joomla 3.6.5, 3.7.3, Magento 2.1.4, 2.1.6, Laravel 5.3 , Codeigniter, Os-commerce, Moodle, and Zen cart Databases : MySQL, PostgreSQL and SQL Web design & Scripting : JavaScript, AJAX, JQuery, HTML, XML, CSS. Operating Systems : Windows Family, Ubuntu and Linux
ACAP, LLC is a Fort Lauderdale-based business software solutions provider established in 2004. With a track record of over 1,000 successful projects for more than 400 clients, ACAP specializes in delivering high-impact, custom software, mobile, and web applications. Their expertise spans various industries, serving both world-class brands like Mercedes and Virgin Mobile, as well as smaller niche and start-up ventures.
Key Features and Functionality:
- Custom Web Applications: Development using technologies such as ASP.NET, PHP, AngularJS, Node.js, Java, and Web Services.
- Custom Mobile Applications: Creation of native and responsive mobile apps for iPhone, Android, iPad, and TV platforms.
- Desktop/Server Applications: Expertise in .NET, Java, VB, and C# for robust desktop and server solutions.
- Database Management: Proficiency with databases including MongoDB, MS SQL Server, Access, MySQL, Oracle, and PostgreSQL.
- Operating Systems: Support for Windows, Linux, Mac, iOS, and Android environments.
- CRM and CMS Solutions: Implementation and customization of platforms like Salesforce, Microsoft CRM, WordPress, Kentico, Joomla, Drupal, and DotNetNuke.
- E-Commerce Development: Building and integrating solutions with Magento, Dezdy, Shopify, WooCommerce, and BigCommerce.
- Comprehensive Development Services: Offering end-to-end services including requirements gathering and analysis, technical design, software architecture, development, testing, maintenance, and hosting.
Primary Value and Solutions Provided:
ACAP's primary value lies in its ability to deliver tailored software solutions that drive business success. By leveraging a full software development lifecycle approach, ACAP ensures that each project is executed with precision, from requirements gathering and analysis to design, development, testing, and maintenance. Their commitment to quality and efficiency helps clients achieve their business objectives, whether it's enhancing operational efficiency, improving customer engagement, or launching new digital products. ACAP's diverse portfolio and adherence to best practices make them a trusted partner for businesses seeking innovative and reliable software solutions.
OASYS NOW is a European health-tech startup dedicated to making personalized healthcare accessible to all. By leveraging certified, privacy-first AI technology, OASYS NOW transforms unstructured medical data into actionable insights, significantly accelerating patient identification for clinical trials. This innovation reduces the time required to match patients from months to mere minutes, thereby expediting the development of life-saving treatments.
Key Features and Functionality:
- ELaiGIBLE CT: An AI-powered pre-screening tool that automatically reads study protocols and scans various patient data formats, including electronic health records (EHRs) and PDFs, in real-time. It provides traceable, evidence-based results to support dynamic screening tasks.
- De-ID: A certified de-identification solution designed for both structured and unstructured health data. It detects sensitive information in diverse formats such as PDFs, scans, clinical notes, and handwriting, enabling secure anonymization or pseudonymization in compliance with GDPR and EHDS standards.
- GRIP: A platform that facilitates the secure collection, enrichment, and connection of real-world health and lifestyle data directly from patients, all under dynamic consent. It offers features like dynamic consent management, patient-reported outcome measures (PROM) tracking, and robust data governance and linkage capabilities.
- CoMPai: A confidential multi-party AI framework that enables cross-border data collaboration without the need to access or transfer raw data. It supports confidential aggregation, is compatible with genomic data formats, and ensures performance-preserving privacy.
Primary Value and User Solutions:
OASYS NOW addresses critical challenges in clinical trial recruitment by automating and streamlining the patient identification process. Traditional methods are often time-consuming and inefficient, delaying the development of essential treatments. By utilizing AI to analyze unstructured medical data, OASYS NOW significantly reduces the time required to match patients with appropriate clinical trials, thereby accelerating research and improving patient outcomes. Additionally, the company's commitment to data privacy and compliance ensures that sensitive health information is handled securely, fostering trust among healthcare providers and patients alike.